Current perspectives on mass spectrometry-based immunopeptidomics: the computational angle to tumor antigen discovery

Abstract excerpt

Identification of tumor antigens presented by the human leucocyte antigen (HLA) molecules is essential for the design of effective and safe cancer immunotherapies that rely on T cell recognition and killing of tumor cells. Mass spectrometry (MS)-based immunopeptidomics enables high-throughput, direct identification of HLA-bound peptides from a variety of cell lines, tumor tissues, and healthy tissues. It involves...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Advanced Proteomics Techniques and Applications
• Share to Peptidase Inhibition and Analysis
• Share to vaccines and immunoinformatics approaches